R Kadakia1,2, Y Zheng3,4, Z Zhang3,5, W Zhang3,6, L Hou3,6, J L Josefson1,2. 1. Division of Endocrinology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA. 2. Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 3. Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 4. Health Sciences Integrated PhD Program, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 5. Driskill Graduate Program in Life Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 6. Robert H. Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Abstract
BACKGROUND: Neonatal adiposity has many determinants and may be a risk factor for future obesity. Epigenetic regulation of metabolically important genes is a potential contributor. OBJECTIVES: The objective of the study is to determine whether methylation changes in the LEP gene in cord blood DNA are impacted by the maternal environment or affect neonatal adiposity measures. METHODS: A cross-sectional study of 114 full-term neonates born to healthy mothers with normal glucose tolerance was performed. Cord blood was assayed for leptin and genome-wide DNA methylation profiles via the Illumina 450K platform. Neonatal body composition was measured by air displacement plethysmography. Multivariate linear regression models and semi-partial correlation coefficients were used to analyze associations. False discovery rate was estimated to account for multiple comparisons. RESULTS: Maternal pre-pregnancy BMI was associated with decreased methylation at five CpG sites near the LEP transcription start site in an adjusted model (false discovery rate <0.022 for each site). The association between maternal BMI and cord blood leptin approached significance (r = 0.18, p = 0.054). Cord blood leptin was positively correlated with neonatal adiposity measures including birth weight (r = 0.45, p < 0.001), fat mass (r = 0.47, p < 0.001) and percent body fat (r = 0.44, p < 0.001). CONCLUSIONS: Maternal pre-pregnancy BMI is strongly associated with decreased cord blood LEP gene methylation and may mediate the well-known association between maternal pre-pregnancy BMI and neonatal adiposity.
BACKGROUND: Neonatal adiposity has many determinants and may be a risk factor for future obesity. Epigenetic regulation of metabolically important genes is a potential contributor. OBJECTIVES: The objective of the study is to determine whether methylation changes in the LEP gene in cord blood DNA are impacted by the maternal environment or affect neonatal adiposity measures. METHODS: A cross-sectional study of 114 full-term neonates born to healthy mothers with normal glucose tolerance was performed. Cord blood was assayed for leptin and genome-wide DNA methylation profiles via the Illumina 450K platform. Neonatal body composition was measured by air displacement plethysmography. Multivariate linear regression models and semi-partial correlation coefficients were used to analyze associations. False discovery rate was estimated to account for multiple comparisons. RESULTS: Maternal pre-pregnancy BMI was associated with decreased methylation at five CpG sites near the LEP transcription start site in an adjusted model (false discovery rate <0.022 for each site). The association between maternal BMI and cord blood leptin approached significance (r = 0.18, p = 0.054). Cord blood leptin was positively correlated with neonatal adiposity measures including birth weight (r = 0.45, p < 0.001), fat mass (r = 0.47, p < 0.001) and percent body fat (r = 0.44, p < 0.001). CONCLUSIONS: Maternal pre-pregnancy BMI is strongly associated with decreased cord blood LEP gene methylation and may mediate the well-known association between maternal pre-pregnancy BMI and neonatal adiposity.
Authors: Elmar W Tobi; Bastiaan T Heijmans; Dennis Kremer; Hein Putter; Henriette A Delemarre-van de Waal; Martijn J J Finken; Jan M Wit; P Eline Slagboom Journal: Epigenetics Date: 2011-02-01 Impact factor: 4.528
Authors: F G Papadopoulou; A M Mamopoulos; A Triantos; T C Constantinidis; J Papadimas; E A Assimakopoulos; G Koliakos; M Mamopoulos Journal: J Matern Fetal Med Date: 2000 Sep-Oct
Authors: Tessa L Crume; Allison L Shapiro; John T Brinton; Deborah H Glueck; Mercedes Martinez; Mary Kohn; Curtis Harrod; Jacob E Friedman; Dana Dabelea Journal: J Clin Endocrinol Metab Date: 2015-01-09 Impact factor: 5.958
Authors: Anne P Starling; John T Brinton; Deborah H Glueck; Allison L Shapiro; Curtis S Harrod; Anne M Lynch; Anna Maria Siega-Riz; Dana Dabelea Journal: Am J Clin Nutr Date: 2014-12-03 Impact factor: 7.045
Authors: A M Linabery; R W Nahhas; W Johnson; A C Choh; B Towne; A O Odegaard; S A Czerwinski; E W Demerath Journal: Pediatr Obes Date: 2012-10-08 Impact factor: 4.000
Authors: Corina Lesseur; David A Armstrong; Alison G Paquette; Devin C Koestler; James F Padbury; Carmen J Marsit Journal: Mol Cell Endocrinol Date: 2013-07-30 Impact factor: 4.102
Authors: Marjory Alana Marcello; Antonio Ramos Calixto; Jacqueline Fatima Martins de Almeida; Mariana Bonjiorno Martins; Lucas Leite Cunha; Camila Ayume Amano Cavalari; Elba C S Etchebehere; Ligia Vera Montalli da Assumpção; Bruno Geloneze; Andre Lopes Carvalho; Laura Sterian Ward Journal: Int J Endocrinol Date: 2015-02-25 Impact factor: 3.257
Authors: E K Do; N L Zucker; Z Y Huang; J C Schechter; S H Kollins; R L Maguire; S K Murphy; C Hoyo; B F Fuemmeler Journal: Pediatr Obes Date: 2018-09-19 Impact factor: 4.000
Authors: Jian V Huang; Andres Cardenas; Elena Colicino; C Mary Schooling; Sheryl L Rifas-Shiman; Golareh Agha; Yinan Zheng; Lifang Hou; Allan C Just; Augusto A Litonjua; Dawn L DeMeo; Xihong Lin; Emily Oken; Marie-France Hivert; Andrea A Baccarelli Journal: Epigenetics Date: 2018-11-13 Impact factor: 4.528
Authors: Christos Bagias; Nithya Sukumar; Yonas Weldeselassie; Oyinlola Oyebode; Ponnusamy Saravanan Journal: Int J Environ Res Public Health Date: 2021-02-16 Impact factor: 3.390